PREOTACT PARATHYROID HORMONE(RDNA ORIGIN) FOR INJECTION Trademark

Trademark Overview

On Wednesday, October 5, 2005, a trademark application was filed for PREOTACT PARATHYROID HORMONE(RDNA ORIGIN) FOR INJECTION with the United States Patent and Trademark Office. The USPTO has given the PREOTACT PARATHYROID HORMONE(RDNA ORIGIN) FOR INJECTION trademark a serial number of 78726924. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 29, 2016. This trademark is owned by NPS Pharmaceuticals, Inc.. The PREOTACT PARATHYROID HORMONE(RDNA ORIGIN) FOR INJECTION trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment or prevention of gastrointestinal disorders, infectious diseases, diseases involving varying levels of calcium in cells and outside cells, neurological or other central nervous system disorders, endocrine disorders, or bone metabolism disorders; pharmaceutical preparations for use in analgesia
preotact parathyroid hormone(rdna origin) for injection

General Information

Serial Number78726924
Word MarkPREOTACT PARATHYROID HORMONE(RDNA ORIGIN) FOR INJECTION
Filing DateWednesday, October 5, 2005
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 29, 2016
Registration Number3687544
Registration DateTuesday, September 22, 2009
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 25, 2006

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"PARATHYROID HORMONE (RDNA ORIGIN) FOR INJECTION"
Goods and ServicesPharmaceutical preparations for the treatment or prevention of gastrointestinal disorders, infectious diseases, diseases involving varying levels of calcium in cells and outside cells, neurological or other central nervous system disorders, endocrine disorders, or bone metabolism disorders; pharmaceutical preparations for use in analgesia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 29, 2016
Primary Code005
First Use Anywhere DateFriday, July 17, 2009
First Use In Commerce DateFriday, July 17, 2009

Trademark Owner History

Party NameNPS Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBedminster, NJ 07921
Party NameNPS Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBedminster, NJ 07921
Party NameNPS Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSalt Lake City, UT 84108

Trademark Events

Event DateEvent Description
Friday, April 29, 2016CANCELLED SEC. 8 (6-YR)
Friday, April 10, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 10, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 15, 2014ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, September 22, 2009REGISTERED-PRINCIPAL REGISTER
Tuesday, August 18, 2009LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, August 18, 2009ASSIGNED TO LIE
Thursday, August 13, 2009ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, July 27, 2009STATEMENT OF USE PROCESSING COMPLETE
Saturday, July 18, 2009USE AMENDMENT FILED
Thursday, July 23, 2009PAPER RECEIVED
Thursday, December 4, 2008EXTENSION 5 GRANTED
Friday, November 21, 2008EXTENSION 5 FILED
Thursday, December 4, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, November 21, 2008PAPER RECEIVED
Wednesday, November 19, 2008APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 19, 2008TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 8, 2008EXTENSION 4 GRANTED
Thursday, June 26, 2008EXTENSION 4 FILED
Thursday, June 26, 2008PAPER RECEIVED
Wednesday, February 13, 2008EXTENSION 3 GRANTED
Friday, January 11, 2008EXTENSION 3 FILED
Tuesday, January 22, 2008PAPER RECEIVED
Friday, September 14, 2007EXTENSION 2 GRANTED
Wednesday, June 27, 2007EXTENSION 2 FILED
Wednesday, June 27, 2007PAPER RECEIVED
Saturday, March 24, 2007EXTENSION 1 GRANTED
Tuesday, January 16, 2007EXTENSION 1 FILED
Tuesday, January 16, 2007PAPER RECEIVED
Tuesday, July 18, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 25, 2006PUBLISHED FOR OPPOSITION
Wednesday, April 5, 2006NOTICE OF PUBLICATION
Thursday, March 9, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, March 3, 2006ASSIGNED TO LIE
Tuesday, February 21, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 21, 2006EXAMINER'S AMENDMENT ENTERED
Tuesday, February 21, 2006EXAMINERS AMENDMENT E-MAILED
Tuesday, February 21, 2006EXAMINERS AMENDMENT -WRITTEN
Tuesday, February 21, 2006EXAMINER'S AMENDMENT ENTERED
Tuesday, February 21, 2006EXAMINERS AMENDMENT E-MAILED
Tuesday, February 21, 2006EXAMINERS AMENDMENT -WRITTEN
Friday, February 17, 2006ASSIGNED TO EXAMINER
Tuesday, October 11, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

origin injection rdna hormone parathyroid preotact disorders diseases pharmaceutical cells preparations central other nervous endocrine analgesia